Zepbound vs Wegovy: Which Works Better for Weight Loss?

If you're exploring prescription weight loss options, you've likely come across both Zepbound and Wegovy. These two medications have transformed how we approach weight management, but they're not identical. Understanding the differences between Zepbound vs Wegovy can help you make an informed decision about which might work better for your goals.

Both medications belong to the GLP-1 receptor agonist family, but they use different active ingredients and work slightly differently in your body. Let's break down what sets them apart.

What Are Zepbound and Wegovy?

Wegovy contains semaglutide, a medication that mimics a hormone called GLP-1 (glucagon-like peptide-1). It was FDA-approved for weight management in 2021 and works by regulating appetite and slowing digestion.

Zepbound contains tirzepatide, which is newer to the weight loss scene. Approved by the FDA in November 2023, Zepbound is unique because it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action may offer additional metabolic benefits.

Both medications are administered as weekly injections and are prescribed alongside diet and exercise for chronic weight management in adults with obesity or overweight with weight-related health conditions.

How Effective Is Each Medication?

When comparing Zepbound vs Wegovy for weight loss results, clinical trials show both medications are highly effective, but Zepbound has a slight edge in the numbers.

In clinical trials, Wegovy helped participants lose an average of 15-17% of their body weight over 68 weeks. That's significant—for someone weighing 250 pounds, that could mean losing 37-42 pounds.

Zepbound demonstrated even more impressive results in its trials. Participants lost an average of 18-22% of their body weight over 72 weeks, depending on the dose. At the highest dose, some participants lost up to 22.5% of their starting weight.

It's important to note that individual results vary considerably. Factors like starting weight, adherence to lifestyle changes, and individual metabolism all play a role in how much weight you'll lose on either medication.

Side Effects: What to Expect

Both Zepbound and Wegovy share similar side effect profiles since they work on related pathways in your body. The most common side effects include:

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Stomach pain
• Headache

These side effects are typically most noticeable when starting the medication or increasing your dose. They often improve over time as your body adjusts.

Some users report that Zepbound may cause slightly more gastrointestinal side effects due to its dual-action mechanism, but research is still emerging on direct comparisons. Both medications carry similar warnings about potential serious side effects, including thyroid tumors, pancreatitis, and gallbladder problems.

Starting with a lower dose and gradually increasing it—as your healthcare provider prescribes—can help minimize side effects with either medication.

Cost Comparison

The price difference between Zepbound vs Wegovy can be substantial, especially without insurance coverage.

Wegovy typically costs around $1,300-$1,500 per month without insurance. Zepbound is similarly priced at approximately $1,000-$1,200 per month at retail pharmacies.

Insurance coverage varies widely. Some plans cover these medications for weight loss, while others only cover them for diabetes management. Many people face high copays or prior authorization requirements.

This is where compounded versions become an attractive option. Compounded semaglutide and tirzepatide offer the same active ingredients at a fraction of the cost, making these treatments accessible to more people who need them.

Which One Works Better?

The honest answer is that "better" depends on your individual situation. Based purely on clinical trial data, Zepbound shows slightly higher average weight loss percentages. However, Wegovy has been available longer and has more real-world data supporting its effectiveness and safety profile.

Some factors to consider when choosing between them:

• Weight loss goals: If you're looking for maximum weight loss potential, Zepbound's trial results are slightly higher
• Availability: Both medications have experienced supply issues; check current availability with your provider
• Cost: Compare what your insurance covers or consider compounded alternatives
• Side effect tolerance: Some people tolerate one medication better than another

The best approach is to discuss your medical history, weight loss goals, and any concerns with a healthcare provider who can personalize the recommendation to your needs. You can find more helpful comparisons on our blog at ozarihealth.com/blog to guide your research.

Key Takeaways

• Zepbound (tirzepatide) and Wegovy (semaglutide) are both highly effective GLP-1 medications for weight loss, with Zepbound showing slightly higher average weight loss in clinical trials (18-22% vs 15-17%)
• Both medications have similar side effect profiles, primarily affecting the digestive system, with symptoms often improving over time
• Cost can be prohibitive for both brand-name medications, but compounded versions offer more affordable access to these same active ingredients
• The "better" choice depends on individual factors including weight loss goals, tolerance, insurance coverage, and provider recommendation—there's no universal answer

Frequently Asked Questions

Can I switch from Wegovy to Zepbound or vice versa?

Yes, it's possible to switch between these medications under medical supervision. Your healthcare provider will guide you on the appropriate starting dose and timing to minimize side effects. Some people switch due to availability issues, side effect tolerance, or if they're not seeing desired results with one medication. Never switch without consulting your provider first.

How long does it take to see results with Zepbound or Wegovy?

Most people begin noticing weight loss within the first 4-8 weeks of treatment, though results vary. Significant weight loss typically occurs over several months as you gradually increase to your maintenance dose. Clinical trials measured outcomes at 68-72 weeks, showing that consistent use over time produces the best results. Remember that these medications work best when combined with dietary changes and increased physical activity.

Are compounded versions as effective as brand-name Zepbound and Wegovy?

Compounded semaglutide and tirzepatide contain the same active ingredients as Wegovy and Zepbound. When prepared by reputable compounding pharmacies following FDA guidelines, they offer a clinically equivalent alternative. The main differences are cost and that compounded medications don't go through the same FDA approval process as brand-name drugs. Many people achieve excellent results with compounded versions at a much more accessible price point.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed providers and shipped to your door. Learn more at ozarihealth.com.

Reviewed by the Ozari Clinical Content Team (OCCT) — health writers and wellness professionals specializing in GLP-1 therapy and metabolic health. This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.